The role of repetitive transcranial magnetic stimulation therapy in functional bowel disease

被引:1
作者
Li, Guangyao [1 ,2 ,3 ,4 ]
Lv, Tingcong [1 ,2 ,3 ]
Jin, Binghui [1 ,2 ,3 ]
Fan, Zhe [1 ,2 ,3 ]
机构
[1] Dalian Med Univ, Peoples Hosp Dalian 3, Dept Gen Surg, Dalian, Peoples R China
[2] Dalian Med Univ, Peoples Hosp Dalian 3, Dept Cent Lab, Dalian, Peoples R China
[3] Dalian Med Univ, Peoples Hosp Dalian 3, Liaoning Prov Key Lab Corneal & Ocular Surface Dis, Dalian, Peoples R China
[4] Dalian Univ Technol, Canc Hosp, Dept Med Oncol, Shenyang, Peoples R China
关键词
functional bowel disease; biophysical therapy; repetitive transcranial magnetic stimulation; brain-gut axis; anxiety; depression; GUT-BRAIN AXIS; GI DISORDERS; METAANALYSIS; DEPRESSION; SYMPTOMS; STRESS; SAFETY; SLEEP; TMS;
D O I
10.3389/fmed.2023.1249672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThis study investigates the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a biophysical therapy for alleviating symptoms of functional bowel disorder (FBD) and associated psychological symptoms by targeting the brain-gut axis.MethodsWe conducted a comparative analysis involving 226 subjects, comprising the FBD group (n = 113) and a healthy control group (n = 113). Within the FBD group, participants were further divided into those who received rTMS therapy (FBD treatment group, n = 63) and those who did not (FBD control group, n = 50). The FBD treatment group was subcategorized based on the number of rTMS treatments received. We evaluated various factors, including gender, age, monthly household income, daily activity level, and sleep quality, as potential risk factors for FBD. Severity assessments of FBD and associated symptoms (constipation, anxiety, depression, and somatization disorders) were conducted using validated scales before and after treatment.ResultsOur findings revealed a higher incidence of FBD in women, with most cases emerging at age 50 or older. We identified lower monthly household income, reduced daily activity levels, and poorer sleep quality as factors associated with a higher likelihood of FBD. FBD patients exhibited higher scores for constipation, anxiety, depression, and somatization disorders compared to healthy controls. rTMS therapy was effective in reducing gastrointestinal symptoms, anxiety, depression, and somatization disorders among FBD patients. Notably, the extent of improvement was positively correlated with the number of rTMS sessions. No adverse effects were observed during the study.ConclusionOur study underscores the efficacy of biophysical therapy, specifically repetitive transcranial magnetic stimulation, in mitigating FBD symptoms and associated psychological distress. The treatment's effectiveness is positively linked to the frequency of rTMS sessions.
引用
收藏
页数:20
相关论文
共 64 条
  • [1] The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease
    Ancona, Angela
    Petito, Claudia
    Iavarone, Irene
    Petito, Valentina
    Galasso, Linda
    Leonetti, Alessia
    Turchini, Laura
    Belella, Daniela
    Ferrarrese, Daniele
    Addolorato, Giovanni
    Armuzzi, Alessandro
    Gasbarrini, Antonio
    Scaldaferri, Franco
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 (03) : 298 - 305
  • [2] Transcranial Magnetic Stimulation: A review about its efficacy in the treatment of alcohol, tobacco and cocaine addiction
    Antonelli, Mariangela
    Fattore, Liana
    Sestito, Luisa
    Di Giuda, Daniela
    Diana, Marco
    Addolorato, Giovanni
    [J]. ADDICTIVE BEHAVIORS, 2021, 114
  • [3] Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome Validation of Symptom Frequency Questionnaire
    Azpiroz, Fernando
    Guyonnet, Denis
    Donazzolo, Yves
    Gendre, David
    Tanguy, Jerome
    Guarner, Francisco
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (07) : E64 - E70
  • [4] Evaluation of latent links between irritable bowel syndrome and sleep quality
    Bellini, Massimo
    Gemignani, Angelo
    Gambaccini, Dario
    Toti, Simona
    Menicucci, Danilo
    Stasi, Cristina
    Costa, Francesco
    Mumolo, Maria Gloria
    Ricchiuti, Angelo
    Bedini, Remo
    de Bortoli, Nicola
    Marchi, Santino
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (46) : 5089 - 5096
  • [5] Ben-Ezra M, 2015, ISR J PSYCHIATR REL, V52, P54
  • [6] Functional gastrointestinal disorders: advances in understanding and management
    Black, Christopher J.
    Drossman, Douglas A.
    Talley, Nicholas J.
    Ruddy, Johannah
    Ford, Alexander C.
    [J]. LANCET, 2020, 396 (10263) : 1664 - 1674
  • [7] Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome
    Breen-Lyles, Margaret
    Decuir, Marijke
    Byale, Anjali
    Smith, Kirk
    Grover, Madhusudan
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (05)
  • [8] Burke MJ, 2019, HAND CLINIC, V163, P73, DOI 10.1016/B978-0-12-804281-6.00005-7
  • [9] High-Dimensional Clustering of 4000 Irritable Bowel Syndrome Patients Reveals Seven Distinct Disease Subsets
    Byale, Anjali
    Lennon, Ryan J.
    Byale, Siddharth
    Breen-Lyles, Margaret
    Edwinson, Adam L.
    Gupta, Ruchi
    Lacy, Brian E.
    Olson, Janet E.
    Houghton, Lesley A.
    Grover, Madhusudan
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 173 - +
  • [10] Carabotti M, 2015, ANN GASTROENTEROL, V28, P203